Incyte (INCY) Interest Coverage Ratio Growth (5y) (2015 - 2026)
Incyte (INCY) Interest Coverage Ratio Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Incyte | 23.97 Bn | 19.95 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.44% |
| Dec 31, 2025 | 8.50% |
| Sep 30, 2025 | 162.62% |
| Jun 30, 2025 | 18.92% |
| Mar 31, 2025 | 16.82% |
| Dec 31, 2024 | 25.03% |
| Sep 30, 2024 | 12.46% |
| Jun 30, 2024 | -47.72% |
| Mar 31, 2024 | -7.80% |
| Dec 31, 2023 | 6.66% |
| Sep 30, 2023 | 181.99% |
| Jun 30, 2023 | 65.81% |
| Mar 31, 2023 | 27.88% |
| Dec 31, 2022 | -17.93% |
| Sep 30, 2022 | 206.92% |
| Jun 30, 2022 | 307.54% |
| Mar 31, 2022 | 42.35% |
| Dec 31, 2021 | 76.85% |
| Sep 30, 2021 | 94.95% |
| Jun 30, 2021 | 53.14% |